Eight Sleep Bets Your Bed Can Diagnose Illness Before Doctors

Eight Sleep, the sleep technology company founded by spouses Alexandra Zatarain and Matteo Franceschetti, is betting that the bed you already own can work as an early health monitor. The company is valued at $1.5 billion after a $50 million round led by Tether Investments in March 2026, and it reports being free-cash-flow positive.

A Mission Rooted in Loss

Zatarain co-founded the company in 2014 after her father died of cancer, an illness that took away his sleep first. Franceschetti, a former securities lawyer and competitive athlete, was driven by his own restless legs syndrome and a nagging question: why was the body’s main recovery window never measured? Together they coined the term “sleep fitness,” recasting rest as something to train and track rather than simply hope for.

Where wearables such as Oura or Whoop only report results, the Pod acts on them overnight, cooling one side of the bed or adjusting the base when a sleeper snores. A paid membership covers the continuous processing of biometric data, which the founders say makes the product a nightly intervention rather than furniture.

Pod 6 and the Push Toward Medicine

The Pod 6, launched on September 23, brings a smaller hub, 20 percent faster cooling and nine times more sensors. Solo sizes start at $1,999, the lowest entry price in the company’s history. Eight Sleep is also pursuing FDA clearance to detect and mitigate sleep apnea, a step that could make the device prescribable and eligible for insurance reimbursement.

The company says cumulative Pod sales are approaching $1 billion, with a presence in 37 countries and more than a billion hours of sleep analyzed. Features such as Hot Flash Mode and Pregnancy Mode target women’s changing sleep needs, an area Zatarain has made her focus. Whether a mattress can truly diagnose disease remains unproven, but investors are backing the vision.